Axsome Therapeutics Inc

Contract, Commercial Operations

United States

Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
BiopharmaceuticalIndustries

Contract, Commercial Operations Analyst

Position Overview

The Contract, Commercial Operations Analyst plays a vital role in integrating and managing new data sets to support PTC's product launches, with a focus on claims data, payer data, and new Specialty Pharmacy Providers. Essential responsibilities include ensuring data quality and validation, enhancing CRM functionality, and coordinating process improvements. This role requires managing cross-functional collaboration, performing data analysis, and maintaining documentation to ensure efficient and accurate reporting solutions.

Responsibilities

  • Ensure Sales team CRM enhancements and new projects are prioritized appropriately with consideration for scalability and ongoing maintenance.
  • Analyze configuration changes working with the Veeva CRM System Administrator (IT).
  • Establish CRM test scripts and coordinate/schedule User Acceptance Testing (UATs) with relevant field users.
  • Determine and coordinate process improvements related to CRM functionality, customer data, and reporting.
  • Improve and enrich data quality within CRM – address, status, affiliations of HCPs, COEs, establish match/merge and stewardship activities.
  • Manage rosters for all field-facing teams along with the on-boarding and off-boarding process.
  • Assess quarterly cyclical alignment changes and conduct impact analysis.
  • Communicate key inputs (ZTT/Roster/Target lists) to all cross-functional partners (Patient Services/BI/IT).
  • Assist in planning and development of integrated change request processes across cross-functional BI/IT departments.
  • Build geographical sales analysis, including: trend analysis, regional data, product rankings, market segmentation, call analysis, and other miscellaneous sales support.
  • Prioritize projects, meet timelines, and exceed quality standards based on incoming and ongoing business needs.
  • Analyze data and data requirements regarding reporting solutions, ensure data quality, and match back to core systems transaction results.
  • Create and maintain SOP documentation of Business Operations solutions (CRM, Reporting, IC), data mapping, data dictionaries, and reporting standards.
  • Perform other tasks and assignments as needed and specified by management.

Requirements

  • Bachelor’s degree in a related business or scientific discipline.
  • A minimum of 5+ years of experience in:
    • Veeva CRM
    • Data stewardship
    • Claims and SP Data experience
    • Managing ZTT/Roster/Target lists
  • A minimum of 3+ years of experience in:
    • Integrated Change (IC)
    • Territory Alignment design
  • Proficiency with Microsoft Office.
  • Experience designing and building visualizations using PowerBI or other business intelligence tools (Tableau, Qlik Sense).
  • Strong interest in learning new tools and software is key.
  • Demonstrated expertise in analytical methodologies, statistics, and implementing structured ways of analyzing business problems.

Company Information

PTC Therapeutics is a global commercial biopharmaceutical company. For over 25 years, our team has been deeply committed to a unified purpose: Extending life’s moments for children and adults living with a rare disease.

At PTC, we cultivate an inclusive culture where everyone feels valued, respected, and empowered. We welcome candidates from all backgrounds to join our team, fostering a strong sense of belonging.

Visit our website to learn more about our company and culture! Site: www.ptcbio.com

Employment Type

Full time

Location Type

  • Information not provided

Salary

  • Information not provided

Skills

Data Quality
Data Validation
CRM
Veeva CRM
Process Improvement
Cross-functional Collaboration
Data Analysis
Documentation
Reporting
Sales Analysis
SOPs
Data Mapping
Data Dictionaries

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters
2012Year Founded
$430.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Performance Bonus
Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.
Potential delays in AXS-07 launch amid growing market anticipation.
Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.
AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.
Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.
Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.
Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI